US United States English
US Estados Unidos Español
PL Polska Polski
ZA South Africa English
ZA Suid-Afrika Afrikaans
South Africa English

Introducing the BTKi-SLE Study: a Systemic Lupus Erythematosus clinical research study

If you have SLE, and are between the ages of 18-75, consider taking part in the BTKi-SLE Study. Learn about the study or see if you may pre-qualify.

Living day in, day out with systemic lupus erythematosus (SLE) can be challenging. It takes courage, persistence and knowing your treatment choices. If SLE is affecting your life, could a clinical research study be an option for you?

The BTKi-SLE Study is a global clinical research study looking at an investigational medication for people with SLE.

SLE is an autoimmune disease that can affect many parts of the body, including the skin, muscles and joints, and even organs located inside your body. This global study will be looking at the safety and effectiveness of an investigational medication in people with SLE and will determine which dose works best. The investigational medication works differently than other medications used to treat SLE.

Thank you for considering this clinical research study.

Learn more about this study.

This website is supported by Merck KGaA.